Stocks making the biggest moves premarket: Walmart, Hims & Hers, Carvana, Figma & more
Check out the companies making the biggest moves in premarket trading: Walmart — The big-box retailer shed 3.7% after its
Read More
Dividends
Stocks making the biggest moves midday: Crocs, Cisco, Lululemon, AppLovin & more
Check out the companies making the biggest moves in midday trading: Crocs — Shares of the clogs manufacturer surged 21%
Read More
Restaurant Brands shares fall despite earnings beat, strong international growth
Restaurant Brands International on Thursday reported quarterly earnings and revenue that topped expectations, fueled by strong international growth. However, executives said that
Read More
McDonald’s earnings beat estimates as chain’s value push pays off
McDonald’s on Wednesday reported quarterly earnings and revenue that topped analysts’ expectations as its value push wins back customers. “By
Read More
Stocks making the biggest moves midday: Ferrari, Incyte, S&P Global, Datadog, BP and more
These are some of the stocks posting the largest midday moves. This article was originally published by a Cnbc.com. Read
Read More
Kraft Heinz pauses work to split the company as new CEO says ‘challenges are fixable’
Kraft Heinz in September 2025 announced plans to split into two separately traded companies, reversing its 2015 megamerger, which was
Read More
Coca-Cola forecasts modest growth amid demand concerns
Coca-Cola on Tuesday reported weaker-than-expected quarterly revenue, falling short of Wall Street’s projections for the first time in five years.
Read More
Fixed-income ETF provider BondBloxx questions private credit meltdown fears, sees space as
BondBloxx ETFs has been making a big bet in private credit. Even with Wall Street fears of an impending meltdown in
Read More
Yum Brands posts mixed quarter, Taco Bell shines
A customer enters a Taco Bell restaurant in El Cerrito, California, US, on Tuesday, April 29, 2025. David Paul Morris
Read More
Pfizer beats quarterly estimates despite Covid product decline, reaffirms modest outlook
Pfizer on Tuesday reported fourth-quarter results that topped estimates even amid dwindling demand for its Covid products, while reaffirming its
Read More